(Alliance News) - The following is a round-up of share dealings by London-listed company directors and managers announced on Monday and Tuesday and not separately reported by Alliance News: Read More
(Alliance News) - Analysts at Shore Capital Markets on Tuesday backed GSK PLC's near and medium-term prospects, but noted the pharmaceutical firm has some work to do to convince the market of its long-term potential. Read More
(Alliance News) - Unilever PLC on Monday said Chief Executive Alan Jope will step down at the end of next year, after five years in the post. Read More
(Alliance News) - Stocks in London ended lower on Tuesday, kicking off a shortened trading week with trepidation ahead of a batch of central bank interest rate decisions. Read More
(Alliance News) - Stocks in London traded in the red at midday on Tuesday as interest-rate decisions from a list of major central banks later this week loomed large. Read More
(Alliance News) - Haleon PLC on Tuesday reported a strong performance in the first half of 2022 in its first earnings report since being split from GSK PLC in July and separately listed, noting double-digit revenue growth and profit rise. Read More
(Alliance News) - Stocks in London were trading broadly higher early on Tuesday, bolstered by a positive first earnings report from GSK's consumer healthcare spin-off Haleon, ahead of a week expected to be dominated by interest rate decisions. Read More
(Alliance News) - Stocks in London are set to open higher on Tuesday, as markets in London return to action following a bank holiday for the state funeral of Queen Elizabeth II. Read More
(Alliance News) - The FTSE 100 ended a largely positive week on solid footing, with markets on Friday continuing to digest some encouraging inflation figures in the US. Read More
(Alliance News) - Stock prices in London were slightly higher at midday on Friday with markets trading on optimism about US inflation, which is showing signs of easing. Read More
(Alliance News) - Shares in GSK PLC and its consumer healthcare spin-off Haleon PLC have seen a rough couple of days in London, as the pair, alongside peers Pfizer Inc and Sanofi SA, stare down a daunting litigation claim. Read More
(Alliance News) - Stock prices in London opened mixed on Friday with Flutter Entertainment leading the FTSE 100, while pharmaceutical companies responded to market concerns about litigation over withdrawn heartburn treatment Zantac. Read More
(Alliance News) - Pfizer late Thursday said it has "significant defences" against Zantac litigation, while Haleon revealed it is "not a party" to any claims. Read More
(Alliance News) - Pfizer Inc late Thursday said it has "significant defences" against Zantac litigation, while Haleon PLC revealed it is "not a party" to any claims. Read More
